These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 9571970

  • 21. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
    Hou M, Li L, Qiu M, Yan X, Zhu J, Gou HF.
    Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
    [Abstract] [Full Text] [Related]

  • 22. Randomized controlled study comparing two doses of intravenous granisetron (1 and 3 mg) for acute chemotherapy-induced nausea and vomiting in cancer patients: a non-inferiority trial.
    Yonemura M, Katsumata N, Hashimoto H, Satake S, Kaneko M, Kobayashi Y, Takashima A, Kato Y, Takeuchi M, Fujiwara Y, Yamamoto H, Hojo T.
    Jpn J Clin Oncol; 2009 Jul; 39(7):443-8. PubMed ID: 19395466
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Goto T, Tanimoto K, Ishibashi M, Okamura S.
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1227-32. PubMed ID: 22902447
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Dix S, Cord M, Howard S, Coon J, Belt R, Geller R.
    Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
    [Abstract] [Full Text] [Related]

  • 30. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY, Xu RH, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW, McGuire BW, Cruickshank SE, Johnson DH.
    Oncologist; 2005 Feb; 10(2):138-49. PubMed ID: 15709216
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy of combination with granisetron and methylprednisolone for nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a randomized comparative trial between granisetron alone and granisetron plus methylprednisolone].
    Ono K, Uchida I, Uno N, Ohno E, Hirota K, Nakayama T, Ohtuka E, Saburi Y, Kikuchi H, Nasu M.
    Gan To Kagaku Ryoho; 1999 May; 26(6):821-8. PubMed ID: 10410152
    [Abstract] [Full Text] [Related]

  • 37. [Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
    Ichida T, Isokawa O, Itoh S, Ohta H, Takagi K, Hatakeyama S, Tsuruya T, Doya Y, Nozawa A, Hata K, Hara H, Hirose S, Watanabe T, Asakura H.
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1939-46. PubMed ID: 9797817
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
    Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, Raftopoulos H, Grunberg SM, Gabriel M, Rodgers A, Bohidar N, Klinger G, Hustad CM, Horgan KJ, Skobieranda F.
    J Clin Oncol; 2005 Apr 20; 23(12):2822-30. PubMed ID: 15837996
    [Abstract] [Full Text] [Related]

  • 39. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
    Hirabayashi N, Goto S, Morishima Y, Sao H, Matsuyama T, Kodera Y, Yamada H, Horibe K, Yano K, Kojima H, Ogura M, Tanimoto M, Morishita Y, Yazaki M, Utsumi M, Nagata K, Kato Y, Naoe T, Saito H.
    Rinsho Ketsueki; 1998 Jan 20; 39(1):21-6. PubMed ID: 9492549
    [Abstract] [Full Text] [Related]

  • 40. Granisetron: is there a dose-response effect on nausea and vomiting?
    Minami M.
    Cancer Chemother Pharmacol; 2003 Aug 20; 52(2):89-98. PubMed ID: 12783208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.